Home › Acute Myeloid Leukemia › Colorado › Aurora

Pag-aaral pangklinika para sa Acute Myeloid Leukemia sa Aurora, CO

16 pag-aaral para sa Acute Myeloid Leukemia ang naghahanap ng mga kalahok sa mga site sa loob at paligid ng Aurora (sa loob ng humigit-kumulang 30 milya). Buksan ang pag-aaral upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

A Study to Find the Highest Dose of Cedazuridine and Decitabine Combination With Filgrastim as a Treatment Option After Hematopoietic Stem Cell Transplant in Children With High-Risk Acute Myeloid Leukemia

Nagre-recruitPhase 1

Children's Hospital Colorado, Aurora

Hanggang edad 21 · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT07012044

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo

Rocky Mountain Regional VA Medical Center, Aurora
UCHealth University of Colorado Hospital, Aurora

Edad 40 hanggang 75 · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT05334069

Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution

Nagre-recruitObservasyonal na pag-aaral

Children's Hospital Colorado, Aurora

Edad 0 hanggang 38 · Lahat ng kasarian · Na-update Okt 1, 2026 · NCT06131801

A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)

Nagre-recruitPhase 3

Rocky Mountain Cancer Centers, Aurora

Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT06852222

A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations

Nagre-recruitPhase 3

Children's Hospital Colorado, Aurora

6 Months – 21 Years · Lahat ng kasarian · Na-update Set 17, 2026 · NCT04293562

A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation

Nagre-recruitPhase 1/2

University of Colorado, Aurora

30 Days · Lahat ng kasarian · Na-update Set 16, 2026 · NCT04065399

CD64 CAR T Cell Therapy in Adults With Relapsed and/or Refractory AML

Nagre-recruitPhase 1

University of Colorado Hospital, Aurora

Edad 18 pataas · Lahat ng kasarian · Na-update Set 2, 2026 · NCT07347418

Eganelisib as Monotherapy and in Combination With Cytarabine in Relapsed/Refractory AML

Nagre-recruitPhase 1

Anshutz Cancer Pavilion, Aurora

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 25, 2026 · NCT06533761

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

Nagre-recruitPhase 1/2

Children's Hospital Colorado, Aurora

Hanggang edad 22 · Lahat ng kasarian · Na-update Ago 25, 2026 · NCT04726241

Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)

Nagre-recruitPhase 3

Children's Hospital Colorado, Aurora

29 Days – 21 Years · Lahat ng kasarian · Na-update Ago 24, 2026 · NCT05183035

Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML

Nagre-recruitPhase 3

University of Colorado, Aurora

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 20, 2026 · NCT07007312

Study of Revumenib, Azacitidine, and Venetoclax in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid Leukemia

Nagre-recruitPhase 1

Children's Hospital Colorado, Aurora

Edad 1 hanggang 30 · Lahat ng kasarian · Na-update Ago 3, 2026 · NCT06177067

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

Nagre-recruitObservasyonal na pag-aaral

Children's Hospital Colorado, Aurora
University of Colorado Hospital, Aurora

Lahat ng edad · Lahat ng kasarian · Na-update Hul 6, 2026 · NCT01351545

IDH Targeted/Non- Targeted vs Non-targeted/IDH-targeted Approaches in the Treatment of Newly Diagnosed IDH Mutated AML Patients Not Candidates for Intensive Induction Therapy (I- DATA Study)

Nagre-recruitPhase 2

University of Colorado, Aurora

Edad 18 pataas · Lahat ng kasarian · Na-update Hun 23, 2026 · NCT05401097

A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML

Nagre-recruitPhase 1

University of Colorado, Aurora

Edad 18 pataas · Lahat ng kasarian · Na-update Mar 13, 2026 · NCT05735184

Study of NMS-03597812 in Adult Patients With Relapsed/Refractory Acute Myeloid Leukemia

Nagre-recruitPhase 1

Rocky Mountain Cancer Centers, Aurora

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 31, 2025 · NCT06549790

Pag-aaral para sa Acute Myeloid Leukemia sa ibang lungsod

Iba pang pag-aaral sa Aurora

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.